LifeStance Health Group (LFST) Stock: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$12.97
-0.03 (-0.23%)
▼
5d:
+1.09%
30d:
+6.05%
90d:
+50.64%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LFST shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LFST shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.08
14.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $12.97, which is considered extended relative to its 30-day fair value range of $11.33 to $12.93. The stock's valuation (Forward PE: 24.4) is in line with its historical norms (23.5). At these levels, the market is pricing in 1.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LFST is in a strong uptrend. Immediate support is located at $12.04, while resistance sits at $14.14.
Market Sentiment: LFST scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LFST is in a strong uptrend. Immediate support is located at $12.04, while resistance sits at $14.14.
Market Sentiment: LFST scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.33 -
$12.93
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($14.20)
- NEUTRAL: Market pricing in 1.4% annual earnings growth - fairly valued
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.33 -
$12.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.04
Resistance Level
$14.15
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.43
Wall Street Target
$14.20
(+9.5%)
Revenue Growth (YoY)
26.1%
Earnings Growth (YoY)
1927.5%
Profit Margin
3.2%
Valuation Premium vs History
+1.4% premium
PE vs Historical
24.4 vs 23.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.4%
(market-implied from PE analysis)
1-Year Target
$13.15
(+1%)
2-Year Target
$13.34
(+3%)
3-Year Target
$13.52
(+4%)
3-Yr Target (if PE normalizes)
(PE: 24→24)
PE COMPRESSION
$13.01
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.4, Growth: 34.2%)
$31.35
(+142%)
Base:
(SPY PE: 20.2, Growth: 34.2%)
$25.88
(+100%)
Bear:
(PE: 17.1, Growth: 34.2%)
$22.00
(+70%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (55x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Forward PE: 54.64 | Forward EPS (Implied): $0.24
Bull Case
$15.66
(+21%)
Analyst growth 15.0%, PE expands to 57.4
Base Case
$12.97
(0%)
Market implied 0.0%, PE stable at 54.6
Bear Case
$9.92
(-24%)
Severe decline -15.0%, PE contracts to 49.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 11, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
